Beijing Wantai Biological Hits Day High with Strong 3.08% Intraday Surge

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. experienced a notable increase of 3.08% on March 6, 2026, reaching an intraday high of CNY 39.45. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.38% on the same day. Despite today's uptick, the stock has faced significant challenges over the longer term. Over the past year, Beijing Wantai has reported a staggering decline of 42.03%, while its performance over three years shows a decrease of 56.5%. The company's net sales for the first nine months have contracted by 22.74%, and it has recorded negative net profits for the last eight consecutive quarters, with a half-year net profit of CNY -134.9 million. The company operates within the pharmaceuticals and biotechnology sector and holds a market capitalization of CNY 50,786 million. However, it has struggled with poor long-term growth metrics, including a negative annual growth rate in net sales and operating profit over the past five years. As the stock continues to navigate a challenging market landscape, its performance remains a focal point for stakeholders.